comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 23:00:21 - browse：1838

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Better Therapeutics data on benefit with GLP

WSS

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Abortion pill Supreme Court ruling could impact entire drug industry

Eliminate the waiting period for sterilization covered by Medicaid

There's no autism epidemic. It's an autism diagnosis epidemic

Decaf coffee targeted by food safety group under obscure FDA rule

Peter Marks talks Operation Warp Speed for Rare Diseases

hotspot

comprehensive

focus

Hollywood unions extend contract negotiations for actors

Abortion pill case raises question: who can sue the FDA?

Hepatitis C has a cure — but many Americans still lack access to it

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Medical records are filled with copy

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Apple is now the first public company to be valued at $3 trillion

Food as medicine: Medically tailored meals may get standardized

Sports medicine is finally prioritizing gender equality

What the Wegovy shortage looks like for doctors — and for patients

leisure time

Washington mulls new rules to avert another Change Healthcare

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Nick Jonas talks about managing diabetes along with his career

Steward Health Care has deal to sell doctor network to UnitedHealth

Steward Health Care has deal to sell doctor network to UnitedHealth

Cancer cells are shown to suck energy source from immune cells

hotspot

leisure time

hotspot

leisure time